• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

YC-1,一种新型血小板鸟苷酸环化酶激活剂。

YC-1, a novel activator of platelet guanylate cyclase.

作者信息

Ko F N, Wu C C, Kuo S C, Lee F Y, Teng C M

机构信息

Pharmacological Institute, College of Medicine, National Taiwan University, Taipei.

出版信息

Blood. 1994 Dec 15;84(12):4226-33.

PMID:7527671
Abstract

YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole] inhibited the aggregation of and ATP release from washed rabbit platelets induced by arachidonic acid (AA), collagen, U46619, platelet-activating factor (PAF), and thrombin in a concentration-dependent manner. YC-1 also disaggregated the clumped platelets caused by these inducers. The thromboxane B2 formation caused by collagen, PAF, and thrombin was inhibited by concentrations of YC-1 that did not affect formation of thromboxane B2 and prostaglandin D2 caused by AA. YC-1 suppressed the increase of intracellular Ca2+ concentration and generation of inositol 1,4,5-trisphosphate caused by these five aggregation inducers. Both the cAMP and cGMP contents of platelets were increased by YC-1 in a concentration- and time-dependent manner. Like sodium nitroprusside, YC-1 potentiated formation of cAMP caused by prostaglandin E1 but not that by 3-isobutyl-1-methylxanthine. Adenylate cyclase and cAMP phosphodiesterase activities were not altered by YC-1. Activity of cGMP phosphodiesterase was unaffected by YC-1. Activities of guanylate cyclase in platelet homogenate and cytosolic fraction were activated by YC-1, whereas particulate guanylate cyclase activity was unaffected. The antiplatelet effect of sodium nitroprusside but not that of YC-1 was blocked by hemoglobin and potentiated by superoxide dismutase. After intraperitoneal administration for 30 minutes, YC-1 prolonged the tail bleeding time of conscious mice. These data indicate that YC-1 is a direct soluble guanylate cyclase activator in rabbit platelets. It may also possess antithrombotic potential in vivo.

摘要

YC-1[3-(5'-羟甲基-2'-呋喃基)-1-苄基吲唑]以浓度依赖的方式抑制花生四烯酸(AA)、胶原、U46619、血小板活化因子(PAF)和凝血酶诱导的洗涤兔血小板的聚集和ATP释放。YC-1还使这些诱导剂引起的聚集血小板解聚。胶原、PAF和凝血酶引起的血栓素B2形成受到YC-1浓度的抑制,而该浓度不影响AA引起的血栓素B2和前列腺素D2的形成。YC-1抑制这五种聚集诱导剂引起的细胞内Ca2+浓度升高和肌醇1,4,5-三磷酸的生成。YC-1以浓度和时间依赖的方式增加血小板的cAMP和cGMP含量。与硝普钠一样,YC-1增强前列腺素E1引起的cAMP形成,但不增强3-异丁基-1-甲基黄嘌呤引起的cAMP形成。YC-1不改变腺苷酸环化酶和cAMP磷酸二酯酶的活性。cGMP磷酸二酯酶的活性不受YC-1影响。YC-1激活血小板匀浆和胞质部分的鸟苷酸环化酶活性,而微粒体鸟苷酸环化酶活性不受影响。血红蛋白可阻断硝普钠的抗血小板作用,但不阻断YC-1的抗血小板作用,超氧化物歧化酶可增强其作用。腹腔注射30分钟后,YC-1延长清醒小鼠的尾部出血时间。这些数据表明,YC-1是兔血小板中一种直接的可溶性鸟苷酸环化酶激活剂。它在体内也可能具有抗血栓形成的潜力。

相似文献

1
YC-1, a novel activator of platelet guanylate cyclase.YC-1,一种新型血小板鸟苷酸环化酶激活剂。
Blood. 1994 Dec 15;84(12):4226-33.
2
YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.YC-1通过可溶性鸟苷酸环化酶的非一氧化氮依赖性激活来抑制人血小板聚集。
Br J Pharmacol. 1995 Oct;116(3):1973-8. doi: 10.1111/j.1476-5381.1995.tb16400.x.
3
Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets.双氢石蒜碱,一种新型抗血小板药物,可抑制血栓素形成并提高兔血小板环磷酸腺苷水平。
Biochem Pharmacol. 1992 Jan 22;43(2):323-9.
4
YC-1 potentiates the antiplatelet effect of hydrogen peroxide via sensitization of soluble guanylate cyclase.YC-1通过使可溶性鸟苷酸环化酶敏感化来增强过氧化氢的抗血小板作用。
Eur J Pharmacol. 1999 Sep 24;381(2-3):185-91. doi: 10.1016/s0014-2999(99)00577-4.
5
Cyclic AMP and cyclic GMP phosphodiesterase inhibition by an antiplatelet agent, 6-[(3-methylene-2-oxo-5-phenyl-5-tetrahydrofuranyl)methoxy)quinol inone (CCT-62).一种抗血小板药物6-[(3-亚甲基-2-氧代-5-苯基-5-四氢呋喃基)甲氧基]喹诺酮(CCT-62)对环磷酸腺苷和环磷酸鸟苷磷酸二酯酶的抑制作用
Eur J Pharmacol. 1998 May 15;349(1):107-14. doi: 10.1016/s0014-2999(98)00181-2.
6
Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.腺苷酸环化酶激活剂与一氧化氮供体SIN-1对血小板环磷酸腺苷的协同相互作用。
Eur J Pharmacol. 1995 May 26;289(3):455-61. doi: 10.1016/0922-4106(95)90154-x.
7
YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.YC-1,一种可溶性鸟苷酸环化酶的非一氧化氮依赖性激活剂,可抑制小鼠富含血小板的血栓形成。
Eur J Pharmacol. 1997 Feb 12;320(2-3):161-6. doi: 10.1016/s0014-2999(96)00911-9.
8
Effect of PP1D-1, a synthetic antiplatelet compound, on rabbit platelets.
Jpn J Pharmacol. 1998 Feb;76(2):141-8. doi: 10.1254/jjp.76.141.
9
Inhibition of platelet function by A02131-1, a novel inhibitor of cGMP-specific phosphodiesterase, in vitro and in vivo.新型cGMP特异性磷酸二酯酶抑制剂A02131-1在体外和体内对血小板功能的抑制作用
Blood. 1996 May 1;87(9):3758-67.
10
Antiplatelet effect of demethyldiisoeugenol.去甲基二异丁香酚的抗血小板作用。
Can J Physiol Pharmacol. 1996 Oct;74(10):1111-6. doi: 10.1139/cjpp-74-10-1111.

引用本文的文献

1
Analysis of research trends and development prospects of soluble guanylate cyclase stimulators/activators: using bibliometric methods.可溶性鸟苷酸环化酶刺激剂/激活剂的研究趋势与发展前景分析:运用文献计量学方法
Front Pharmacol. 2025 Jun 10;16:1501330. doi: 10.3389/fphar.2025.1501330. eCollection 2025.
2
Unbiased high-throughput screening of drug-repurposing libraries identifies small-molecule inhibitors of clot retraction.对药物再利用文库进行无偏倚的高通量筛选,可鉴定出凝块回缩的小分子抑制剂。
Blood Adv. 2025 Mar 11;9(5):1049-1068. doi: 10.1182/bloodadvances.2024013810.
3
Hypoxia and the endometrium: An indispensable role for HIF-1α as therapeutic strategies.
缺氧与子宫内膜:HIF-1α 作为治疗策略的不可或缺作用。
Redox Biol. 2024 Jul;73:103205. doi: 10.1016/j.redox.2024.103205. Epub 2024 May 21.
4
Targeting Soluble Guanylyl Cyclase during Ischemia and Reperfusion.靶向缺血再灌注期间的可溶性鸟苷酸环化酶。
Cells. 2023 Jul 21;12(14):1903. doi: 10.3390/cells12141903.
5
Erectile Dysfunction: Treatments, Advances and New Therapeutic Strategies.勃起功能障碍:治疗方法、进展与新治疗策略
Brain Sci. 2023 May 15;13(5):802. doi: 10.3390/brainsci13050802.
6
Role of the Coiled-Coil Domain in Allosteric Activity Regulation in Soluble Guanylate Cyclase.卷曲螺旋域在可溶性鸟苷酸环化酶变构活性调节中的作用。
Biochemistry. 2023 May 16;62(10):1568-1576. doi: 10.1021/acs.biochem.3c00052. Epub 2023 May 2.
7
SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancers.SULT1A1 依赖性烷化剂磺化作用是肝癌的谱系依赖性脆弱性。
Nat Cancer. 2023 Mar;4(3):365-381. doi: 10.1038/s43018-023-00523-0. Epub 2023 Mar 13.
8
Carbon monoxide signaling and soluble guanylyl cyclase: Facts, myths, and intriguing possibilities.一氧化碳信号转导与可溶性鸟苷酸环化酶:事实、迷思与饶富趣味的可能性。
Biochem Pharmacol. 2022 Jun;200:115041. doi: 10.1016/j.bcp.2022.115041. Epub 2022 Apr 18.
9
Synthetic strategy and structure-activity relationship (SAR) studies of 3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole (YC-1, Lificiguat): a review.3-(5'-羟甲基-2'-呋喃基)-1-苄基吲唑(YC-1,利福昔呱)的合成策略与构效关系(SAR)研究综述
RSC Adv. 2021 Dec 20;12(1):251-264. doi: 10.1039/d1ra08120a.
10
The sGC stimulator BAY-747 and activator runcaciguat can enhance memory in vivo via differential hippocampal plasticity mechanisms.sGC 刺激剂 BAY-747 和激动剂瑞卡鲁肽可通过不同的海马可塑性机制在体内增强记忆。
Sci Rep. 2022 Mar 4;12(1):3589. doi: 10.1038/s41598-022-07391-1.